CHINAAMC Hang Seng Biotech ETF (HKG:9069)
Hong Kong
· Delayed Price · Currency is HKD · Price in USD 1.652
+0.010 (0.61%)
Last updated: Jun 23, 2025
67.38% (1Y)
| Assets | n/a |
| Expense Ratio | 0.50% |
| PE Ratio | n/a |
| Dividend (ttm) | 0.06 |
| Dividend Yield | 0.47% |
| Ex-Dividend Date | Dec 18, 2024 |
| Payout Frequency | Annual |
| Payout Ratio | n/a |
| 1-Year Return | +67.38% |
| Volume | n/a |
| Open | 1.652 |
| Previous Close | 1.642 |
| Day's Range | 1.652 - 1.652 |
| 52-Week Low | 0.936 |
| 52-Week High | 1.858 |
| Beta | n/a |
| Holdings | 10 |
| Inception Date | Mar 18, 2021 |
About 9069
CHINAAMC Hang Seng Biotech ETF is headquartered in Beijing, China.
Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9069
Provider ChinaAMC
Index Tracked Hang Seng Hong Kong-Listed Biotech Index - HKD - Benchmark TR Net
Performance
9069 had a total return of 67.38% in the past year, including dividends. Since the fund's inception, the average annual return has been -12.10%.
Top 10 Holdings
59.02% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi Biologics (Cayman) Inc. | 2269 | 10.69% |
| BeOne Medicines Ltd. | BEIGF | 9.75% |
| Innovent Biologics, Inc. | 1801 | 8.43% |
| Akeso, Inc. | 9926 | 6.30% |
| CSPC Pharmaceutical Group Limited | 1093 | 4.94% |
| Sino Biopharmaceutical Limited | 1177 | 4.75% |
| Giant Biogene Holding Co., Ltd. | 2367 | 4.00% |
| Zai Lab Limited | 9688 | 3.63% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 3.56% |
| WuXi AppTec Co., Ltd. | 2359 | 2.96% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2024 | 0.060 HKD | Dec 31, 2024 |
| Dec 18, 2023 | 0.02997 HKD | Dec 29, 2023 |
| Dec 19, 2022 | 0.03997 HKD | Dec 30, 2022 |